Cargando…

Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis

Uveal melanoma is an aggressive intraocular malignancy that often exhibits low immunogenicity. Metastatic uveal melanoma samples frequently exhibit monosomy 3 or BAP1 deficiency. In this study, we used bioinformatic methods to investigate the immune infiltration of uveal melanoma samples in public d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Hui, Lu, Linna, Cui, Junqi, Yang, Yuan, Wang, Zhaoyang, Fan, Xianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053626/ https://www.ncbi.nlm.nih.gov/pubmed/31954372 http://dx.doi.org/10.18632/aging.102693

Ejemplares similares

DNA Repair Genes Are Associated with Subtype Classification, Prognosis, and Immune Infiltration in Uveal Melanoma
por: Wang, Tao, et al.
Publicado: (2022)

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression
por: Lu, Linna, et al.
Publicado: (2017)

Uveal melanoma: progress in molecular biology and therapeutics
por: Li, Yongyun, et al.
Publicado: (2020)

Uveal melanoma: Estimating prognosis
por: Kaliki, Swathi, et al.
Publicado: (2015)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
por: Cheng, Yanhua, et al.
Publicado: (2022)

Fatty acid-binding protein 5 predicts poor prognosis in patients with uveal melanoma
por: Xu, Yue, et al.
Publicado: (2020)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Immunological significance of survival-related alternative splicing in uveal melanoma
por: Kong, Deqian, et al.
Publicado: (2022)

SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27
por: Zhao, Hongbo, et al.
Publicado: (2019)

EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation
por: Neumann, Lisa C, et al.
Publicado: (2011)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
por: Li, Yue, et al.
Publicado: (2023)

Publication trends of research on uveal melanoma during 2000–2020: a 20-year bibliometric study
por: Xie, Minyue, et al.
Publicado: (2020)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Identification of Immune-Related lncRNAs for Predicting Prognosis and Immune Landscape Characteristics of Uveal Melanoma
por: Chen, Wei, et al.
Publicado: (2022)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma
por: Huang, Wei, et al.
Publicado: (2023)

HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
por: Souri, Zahra, et al.
Publicado: (2019)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Targeted Silencing of MART-1 Gene Expression by RNA Interference Enhances the Migration Ability of Uveal Melanoma Cells
por: Zhang, Yidan, et al.
Publicado: (2013)

Expression of EZH2 in uveal melanomas patients and associations with prognosis
por: Cheng, Ying, et al.
Publicado: (2017)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma
por: Zhu, Ru, et al.
Publicado: (2023)

Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma
por: Cui, Yi, et al.
Publicado: (2021)

Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior
por: Li, Ke, et al.
Publicado: (2023)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Uveal Melanoma Metastasis
por: Rossi, Ernesto, et al.
Publicado: (2021)

Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma
por: Gentien, David, et al.
Publicado: (2023)

A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma
por: Liu, Jun, et al.
Publicado: (2021)

Epigenetic drug library screening reveals targeting DOT1L abrogates NAD(+) synthesis by reprogramming H3K79 methylation in uveal melanoma
por: Gu, Xiang, et al.
Publicado: (2023)

EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
por: Lv, Yufei, et al.
Publicado: (2022)

Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma
por: Sun, Yabin, et al.
Publicado: (2022)

Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes
por: Kucherlapati, Melanie
Publicado: (2018)

Improved Uveal Melanoma Copy Number Subtypes Including an Ultra–High-Risk Group
por: Lalonde, Emilie, et al.
Publicado: (2022)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
por: Hu, Shuiqing, et al.
Publicado: (2012)

The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma
por: Zhang, Leilei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kma18sm01q4cpa8kkcucpeva98